Stay updated on Gene Transfer for SMA Type 1 Clinical Trial

Sign up to get notified when there's something new on the Gene Transfer for SMA Type 1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gene Transfer for SMA Type 1 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added, replacing the previous v3.6.2. This indicates a behind-the-scenes update to the page's platform or content-management system rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-07-03T22:25:19.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor internal update. This change does not alter the study content or public-facing information.
    Difference
    0.1%
    Check dated 2026-06-26T22:50:20.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page adds recruitment visibility updates and new help sections for joining and understanding the study, while an existing label formatting for Intervention/Treatment changes and a new revision note (v3.6.0) were introduced.
    Difference
    0.5%
    Check dated 2026-06-12T16:26:49.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.5.4 to v3.5.5, reflecting a software update rather than changes to the study information.
    Difference
    0.1%
    Check dated 2026-06-05T16:44:41.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new 2021 Drug Saf publication citation is added, and the Erratum citation from 2022 is removed. The page revision is updated to v3.5.4.
    Difference
    0.1%
    Check dated 2026-05-15T06:53:09.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page now includes an additional referenced publication related to onasemnogene abeparvovec in spinal muscular atrophy type 1. The page revision/version label has also been updated from the previous revision number.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:49.000Z thumbnail image

Stay in the know with updates to Gene Transfer for SMA Type 1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gene Transfer for SMA Type 1 Clinical Trial page.